Microsoft Partners with SRL in India to Expand AI Network to Detect Cancer

0

After the training, its artificial intelligence (AI) system for cardiology and eye care, Microsoft India announced on Tuesday their partnership with SRL Diagnostics to expand the ‘AI Network for Healthcare’ to pathology to detect cancer.

The collaboration will help to improve the quality of digital pathology for the screening of population by bringing together Microsoft’s Azure and AI innovations along with SRL’s expertise in the study of cells and tissues (histology).

“Microsoft is committed to empowering both the healthcare industry and patients by using artificial intelligence to democratise healthcare for all. our partnership with SRL Diagnostics will help to assist pathologist by equipping them with the technology that will augment their capability,” Managing Director, Microsoft India (R&D) Pvt Ltd, Anil Bhansali, said in a statement.

As part of its partnership, Microsoft will design an AI platform to create a software environment by using SRL’s repository of more than a million histopathology slides.

Image Source: Microsoft

By increasing the efficiency in the initial steps ina biopsy tissue analysis through artificial neural networks, it’ll be possible for a pathology laboratory to cut down on manual errors and process more samples in a day with a high level of accuracy.

“Diagnosis is the first step towards disease management. Without the accurate identification of the cause, there’s no possibility of a precise treatment. With the increasing number of samples of cancer, as well as of other diseases, there is a need to quickly and precisely analyse the samples to help the doctors to arrive at a diagnosis faster,” Chief Executive Officer at SRL Diagnostics, Arindam Haldar said.

The “Artificial Intelligence Network for Healthcare” which aims to maximise the ability of AI and cloud computing to speed up innovation in the healthcare industry and improve the lives of people all around the world.

Earlier, Microsoft had applied Artificial Intelligence to devices for the early detection of ‘diabetic retinopathy’ to prevent blindness and an ‘AI-powered Cardiovascular Disease Risk Score’ API (Application Programme Interface).

This will be the third area where the tech giant has expanded the AI Network for Healthcare, Bhansali said in a statement. “We’ll continue to look for other areas where we can use technology to make health care more accessible.”